1.
|
An open label, multicenter, randomized, controlled clinical trial to evaluate the efficacy and safety of Tablets of purified aqueous extract of Cocculus hirsutus in treatment of
moderate COVID -19 disease
|
India Clinical research and SPPL
|
Extramural
|
|
Completed
|
PI –
Dr Abhishek Singhai
|
2.
|
Factors associated with sudden deaths among adults aged 18–45 years, India: Multicentric matched case-control study” funded by ICMR.
|
ICMR-NIE
|
Extramural
|
|
Completed
|
PI –
Dr Abhishek Singhai
CO-PI –
Dr Mahadev Meena
|
3.
|
A community based screening programme to detect Nonalcoholic Fatty Liver Disease by Fibroscan in Healthy Adults
|
ICMR
|
Extramural
|
|
Ongoing
|
PI –
Dr Abhishek Singhai
|
4.
|
Molecular Profile of Factor VIII Gene Mutation as Predictive Marker for Inhibitor Development in Patient with Hemophilia A
|
ICMR
|
Extramural
|
|
Running
|
CO-PI –
Dr Mahadev Meena
|
5.
|
Development and validation of a deprescribing tool relevant to Indian context and evaluation of its in reducing inappropriate polypharmacy in elderly
|
ICMR
|
Extramural
|
|
Running
|
CO-PI –
Dr Mahadev Meena
|
6.
|
Evaluation of the POC device for spot detection /diagnosis of life-threatening infectious disease tuberculosis.
|
Integri biotech Pvt.Ltd
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
CO-PI -
Dr M. Sukumar
|
7.
|
Association of triglyceride-glucose index (TyG Index) with glycated
hemoglobin for predicting the glycemic control status among Rpe 2 diabetes
mellitus subjects attending AIIMS Bhopal hospital of Central India.
|
IHEC
|
Intramural
|
|
Running
|
CO-PI –
Dr M. Sukumar
|
8.
|
Analysis of influence of dominant somatotype on physical fitness and happiness
of adults affected by non- communicable diseases visiting a tertiary care Centre AIIMS
Bhopal of Central India”
|
SERB
|
Extramural
|
|
Running
|
CO-PI –
Dr M. Sukumar
|
9.
|
EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation
(ENRICH-AF)
|
Hamilton Health Sciences,
through its Population Health Research Institute
|
Extramural
|
|
Running
|
CO-PI –
Dr M. Sukumar
|
10.
|
Harmonized diagnostic assessment of Dementia (DAD) for
longitudinal aging study in India [LASI WAVE 2].
|
NIA/NIH
|
Extramural
|
|
Running
|
CO-PI –
Dr M. Sukumar
|
11.
|
Health related effects of air and water pollution due to fly ash generation from Thermal Power Plants in Singrauli district of M.P
|
M.P. POLLUTION CONTROL BOARD
|
Extramural
|
|
Running
|
CO-PI –
Dr M. Sukumar
|
12.
|
Tuberculosis recurrence after completion of treatment in tertiary care hospital in Central India: Relapse or reinfection-a genomic approach
|
SERB
|
Extramural
|
|
Running
|
CO-PI –
Dr M. Sukumar
|
13.
|
Multicentre implementation research study on high quality acute emergency care systems
|
ICMR
|
Extramural
|
|
Running
|
CO-PI –
Dr Rajnish Joshi
Dr Akash Pawar
|
14.
|
“Implementation of Anti-Microbial Stewardship Program (AMSP) at AIIMS Bhopal
|
ICMR
|
Extramural
|
|
Running
|
PI –
Dr Sagar Khadanga
|
15.
|
Repurposing Clofazimine as part of first line Anti TB regimen in order to shorten the overall duration of treatment in patients with susceptible TB (CORTAIL trial)
|
ICMR
|
Extramural
|
|
Completed
|
CO-PI –
Dr Sagar
Khadanga
|
16.
|
Diagnosis of pneumonia and respiratory illnesses using digital stethoscope and algorithm in children and adults’ Phase I: Development of algorithm for differentiating various respiratory illnesses using lung sounds and clinical parameters.
|
Inclane
|
Extramural
|
|
Completed
|
CO-PI –
Dr Sagar Khadanga
|
17.
|
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care (solidarity Plus)
|
WHO
|
Extramural
|
|
Completed
|
C0-I –
Dr Sagar Khadanga
|
18.
|
Development of Anti Microbial Stewardship IEC material for NHM MP
|
NHM-MP
|
Extramural
|
|
Completed
|
Lead –
Dr Sagar
Khadanga
|
19.
|
Strengthening Infection Prevention and Control in Madhya Pradesh
|
WHO
|
Extramural
|
|
Completed
|
Lead –
Dr Sagar Khadanga
|
20.
|
A Multicentric, Clinico-epidemiological Study to Enhance Diagnostic Capacity for Melioidosis in Madhya Pradesh.
|
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
21.
|
Flowcytometric analysis of lymphocyte cytokine expression in tubercular effusion samples
|
State Task Force, Madhya Pradesh
|
Extramural
|
|
Running
|
CO-I-
Dr Sagar Khadanga
|
22.
|
Assessment of the barriers in tuberculosis noiifiaction in the state of Madhya Pradesh: A qualitative study
|
State Task Force, Madhya Pradesh
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khdanga
|
23.
|
Effect of exercise and yoga program on renin-angiotensin mechanism in cardiac autonomic neuropathy in diabetes mellitus patients.
|
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar Khadanga
|
24.
|
Establishing a Public Health Pharmacy (PHP) Model for theDevelopment of a Multifaceted Antimicrobial Stewardship in anIndian Ambulatory Care Setting
|
Pfizer Global Medical Grants
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
25.
|
Comprehensive Whole Genome Sequencing and reporting of drug resistance profiles of Non-Tuberculous Mycobacteria isolates from Central India
|
DST New Delhi
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
26.
|
“Clinical validation of a New In-house Multiplex PCR for rapid and accurate Diagnosis of Non-Tuberculous Mycobacterial Infections"
|
ICMR
New Delhi
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
27.
|
Identification of Nontuberculous Mycobacteria species from routine clinical samples under NTEP by Line Probe Assay
|
State Task Force, Madhya Pradesh
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
28.
|
“National Clinical Registry of COVID- 19”
|
ICMR
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
29.
|
Expansion of antimicrobial stewardship program(AMSP) and infection prevention & control program (IPC) of ICMR in secondary care hospitals
|
ICMR
|
Extramural
|
|
Completed
|
PI –
Dr Sagar
Khadanga
|
30.
|
Mycology Centre for providing comprehensive diagnostic, therapeutic, training and research facilities in central region of India (i-MARC–ICMR Mycology Advanced Resource Centre)
|
ICMR
|
Extramural
|
|
Ongoing
|
CO-I –
Dr Sagar
Khadanga
|
31.
|
Development of Mycobacterium W for COVID19: Safety and efficacyTrial in critically ill patients
|
CSIR
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
32.
|
Development of Mycobacterium W for COVID19: Safety and efficacy trial in Hospitalized but not seriously ill patients
|
CSIR
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
33.
|
Development of Mycobacterium W for COVID19: Safety and efficacy Trial in in at risk patients
|
CSIR
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
34.
|
WHO-India Solidarity trial
|
WHO-
ICMR
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
35.
|
Development of Rapid Electrochemical based Diagnostics for Detection of SARS CoV2Infection
|
SERB
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
36.
|
Genetic Diversity of Nontuberculous Mycobacteria in Central India Rapid Identification and differentiation ofMycobacterium species byPRA hsp65geneand16S-23SITS region of DNA
|
SERB DST
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
37.
|
Rapid identification of Covid-19 biomarkers in blood plasma using Raman spectroscopy and artificial intelligence
|
SERB
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
38.
|
Pectin derived prebiotics as adjuvants for prophylactic treatment of Corona and other similar virus diseases
|
CSIR
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
39.
|
Estimating Incremental Cost of treating Antimicrobial Resistant infections in India
|
ICMR
|
Extramural
|
|
Completed
|
PI –
Dr Sagar Khadanga
|
40.
|
Comprehensive Omics studies to understand the biology of drug resistant Mycobacterium tuberculosis clinical isolates from Arunachal Pradesh” Funded by DBT
|
DBT
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
41.
|
AIIMS Bhopal: Initiating Antimicrobial Stewardship activities in hospitals in India”
|
ICMR
|
Extramural
|
|
Completed
|
PI –
Dr Sagar
Khadanga
|
42.
|
Blood Test for All Forms of Active Tuberculosis (TB) for Commercial ization in India
|
USISTEF
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
43.
|
Capacity Building and Strengthening of Hospital Infection Control to detect and prevent antimicrobial resistance in India
|
CDC
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
44.
|
AIIMS Bhopal Regional Centre for Antimicrobial Resistance Surveillance Network
|
ICMR
|
Extramural
|
|
Running
|
CO-I –
Dr Sagar
Khadanga
|
45.
|
Diagnostic accuracy of Foldscope and feasibility of its use in malaria control program under NVBDCP
|
DBT
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
46.
|
“Primary prevention of cardiovascular events in an urban slum: A household Level Cluster Randomized trial
|
ICMR
|
Extramural
|
|
Completed
|
CO-I –
Dr Sagar
Khadanga
|
47.
|
A community based screening
programme to detect Nonalcoholic
Fatty Liver Disease by Fibroscan in
Healthy Adults
|
ICMR
|
Extramural
|
|
Completed
|
CO-PI –
Dr Vaibhav
Ingle
|
48.
|
Pharmacogenomic and Metabolomic Approaches to Predict Methotrexate Responsiveness in Rheumatoid Arthritis
|
SERB
DST
|
Extramural
|
|
Running
|
PI –
Dr Vaibhav
Ingle
|
49.
|
WHO/ICMR Solidarity Trial
|
ICMR
|
Extramural
|
|
Completed
|
Clinician Participant -
Dr Vaibhav
Ingle
|
50.
|
4. Algorithm-based interventional approach for diagnosing and treatment of
undifferentiated fever with special emphasis on Scrub Typhus and
Brucellosis in Mandsaur, Jabalpur and Satna districts of Madhya Pradesh.
|
NHM
IDSP
|
Extramural
|
|
Running
|
CO-I –
Dr Vaibhav
Ingle
|
51.
|
ICMR’s Network of pulmonary
Fibrosis
|
ICMR
|
Extramural
|
|
Running
|
CO-I –
Dr Vaibhav
Ingle
|
52.
|
Effect of COVID-19 vaccine on thrombotic events among 18-45 year old population in India,
2022: Multicentric hospital-based matched case-control study
|
ICMR
|
Extramural
|
|
Running
|
CO-PI –
Dr Vaibhav
Ingle
|
53.
|
Improving population healthcare-seeking and community engagement for prevention and control of Non-Communicable Diseases Care in India
|
ICMR
|
Co-PI
|
|
Ongoing
|
|
54.
|
Impact, cost-effectiveness, and sustainability of a synergistic, multipronged, customized, low-cost intervention package (IP) to reduce cardiovascular disease (CVD) burden among diverse populations across India.
|
ICMR
|
|
|
Ongoing
|
|
55.
|
An implementation research study on developing a high quality patient-centric integrated model for emergency care systems in selected districts of India
|
ICMR
|
COPI
|
|
ONGOING
|
|
56.
|
National COVID Registry of COVID-19
|
ICMR
|
COPI
|
|
ONGOING
|
|
57.
|
To study the Pulmonary functions in COVID 19 Survivors and the role of a Selective YOGA regime on pulmonary function
|
DST-Satyam
|
Co-Investigator
|
|
Completed
|
|
56.
|
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care
|
NARI-ICMR-WHO
|
Principal Investigator
|
|
Completed
|
|
58.
|
A clinical trial to evaluate the safety and efficacy of Mycobacterium w in critically ill patients suffering from COVID 19 infection
|
CSIR
|
Co-Investigator
|
|
Completed
|
|
59.
|
A Randomized Double-blind, Two arm, controlled ClinicalTrial to compare the efficacy and Safety of Mycobacterium w (Mw) administered along with standard of care versusplacebo administered alongwith standard of care in adult, COVID 19 positive patients hospitalised but notcritically ill
|
CSIR
|
Co-Investigator
|
|
COMPLETED
|
|
60.
|
A Randomized Double-blind, Two arm, Placebo Controlled Clinical Trial to Evaluate the efficacy and Safety of Mycobacterium win preventing COVID-19 in subjects at risk of getting infected with COVID-19
|
CSIR
|
Co-Investigator
|
|
COMPLETED
|
|
61.
|
Health literacy among vulnerable socio-economic groups of Madhya Pradesh, readability assessment of IEC materials in public domain and development of optimal evidence-based health information
|
ICMR
|
CO-PI
|
|
COMPLETED
|
|
62.
|
Density mapping and characterization of non-communicable disease related built environment attributes in urban slums of Bhopal
|
ICMR_NIREH
|
CO-PI
|
|
COMPLETED
|
|
63.
|
AIIMS Bhopal: Initiating Antimicrobial Stewardship activities in hospitals in India
|
ICMR
|
CO-PI
|
|
COMPLETED
|
|
64.
|
Feasibility of Community Health Worker based cardiovascular risk reduction strategies in urban slums of Bhopal
|
ICMR Adhoc
|
PI
|
|
COMPLETED
|
|
65.
|
NCD STEPS Survey in Rural areas of Madhya Pradesh
|
ICMR Adhoc
|
CO-PI
|
|
COMPLETED
|
|
65.
|
National NCD-NPCDCS Study (MP, CG, JH states)
|
NCDIR
|
CO-PI
|
|
COMPLETED
|
|